These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy. Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S; J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055 [TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant androgen deprivation preceding to radical prostatectomy--its role in short-term and long-term outcomes]. Homma Y Nihon Rinsho; 1998 Aug; 56(8):2162-6. PubMed ID: 9750527 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological significance of neoadjuvant hormonal therapy prior to radical prostatectomy: whole section analysis]. Uemura H; Cho M; Hirao Y; Konishi N Hinyokika Kiyo; 2002 Nov; 48(11):719-23. PubMed ID: 12512148 [TBL] [Abstract][Full Text] [Related]
11. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases]. Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant hormone therapy: the Canadian trials. Klotz L; Gleave M; Goldenberg SL Mol Urol; 2000; 4(3):233-7;discussion 239. PubMed ID: 11062379 [TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for prostate cancer. Berry WR N C Med J; 2006; 67(2):154-7. PubMed ID: 16752722 [No Abstract] [Full Text] [Related]
14. Re: Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated? Jani A; Vogelzang NJ J Urol; 2001 Aug; 166(2):631-2. PubMed ID: 11458102 [No Abstract] [Full Text] [Related]
15. Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer. Furukawa J; Miyake H; Takenaka A; Hara I; Fujisawa M BJU Int; 2007 Aug; 100(2):310-4. PubMed ID: 17511772 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer. Sonpavde G; Chi KN; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Berry WR; Kadmon D Cancer; 2007 Dec; 110(12):2628-39. PubMed ID: 17941029 [TBL] [Abstract][Full Text] [Related]